Skip to search formSkip to main contentSkip to account menu

METAVIR Fibrosis Score

A scoring system for liver fibrosis developed by Bedossa and Poynard (Bedossa P, Poynard T. An algorithm for the grading of activity in chronic… 
National Institutes of Health

Related topics

Related topics

1 relation
Clinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Quantification of hepatic perfusion and hepatocyte function with dynamic gadoxetic acid-enhanced MRI in patients with chronic liver disease.
The purpose of the present study was to develop and perform initial validation of dynamic MRI enhanced with gadoxetic acid as… 
2018
2018
Baseline NS5A resistance associated substitutions may impair DAA response in real‐world hepatitis C patients
Oral DAA have demonstrated high efficacy as treatment of hepatitis C. However, the presence of resistance‐associated… 
2016
2016
Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/hepatitis C virus-coinfected patients with advanced liver disease
Aim:We aimed to investigate the safety and efficacy of interferon (IFN) and ribavirin (RBV)-free therapy with sofosbuvir along… 
2016
2016
Serum YKL-40 in young patients with β-thalassemia major: Relation to hepatitis C virus infection, liver stiffness by transient elastography and cardiovascular complications.
Highly Cited
2015
Highly Cited
2015
Sofosbuvir and simeprevir for treatment of hepatitis C virus infection in liver transplant recipients
Recurrent hepatitis C virus (HCV) infection occurs universally in the allograft in the absence of effective antiviral therapy… 
2015
2015
Long-Term Survival and Liver-Related Events after Pegylated Interferon/Ribavirin Therapy in HIV-Infected Patients with Chronic Hepatitis C
Background Sustained HCV clearance after hepatitis C therapy is associated with reduced liver-related complications and death. It… 
2013
2013
Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon…
Objectives Previous studies, mostly retrospective using conventional interferon, have suggested a favorable prognosis for… 
2011
2011
Validation of P2/MS and other noninvasive fibrosis scoring systems in the Korean population with nonalcoholic fatty liver disease.
BACKGROUND/AIMS P2/MS is a noninvasive marker for detecting hepatic fibrosis in patients with viral hepatitis. However, the… 
Highly Cited
2008
Highly Cited
2008
Low Response to Pegylated Interferon plus Ribavirin in HIV-Infected Patients with Chronic Hepatitis C Treated with Abacavir
Background There is little information about the influence of antiretroviral drugs on the antiviral activity of pegylated… 
2008
2008
Response to pegylated interferon plus ribavirin in HIV‐infected patients with chronic hepatitis C due to genotype 4
Summary.  Hepatitis C virus (HCV) genotypes 1 and 4 respond less well to pegylated interferon (pegIFN) plus ribavirin (RBV… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)